INHIBIKASE THERAPEUTICS
Inhibikase Therapeutics has developed the first small molecule platform capable of treating both bacterial and viral infectious disease through a common mechanism of action in the host. The Company's host targeting strategy creates multi-pathogen anti-infectives without stimulating resistance.
INHIBIKASE THERAPEUTICS
Industry:
Health Care Health Diagnostics Therapeutics
Founded:
2008-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.inhibikase.com
Total Employee:
51+
Status:
Active
Contact:
617-936-0184
Total Funding:
1.27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics
Similar Organizations
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke investment in Grant - Inhibikase Therapeutics
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Inhibikase Therapeutics
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Inhibikase Therapeutics
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Inhibikase Therapeutics
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Inhibikase Therapeutics
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Inhibikase Therapeutics
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Inhibikase Therapeutics
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Inhibikase Therapeutics
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Inhibikase Therapeutics
Official Site Inspections
http://www.inhibikase.com Semrush global rank: 5.16 M Semrush visits lastest month: 1.56 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
